CATALYSTSeekingAlpha • 12d ago
Inogen: Cheap Enough To Take A Chance OnInogen (INGN) upgraded to Buy: operational improvements, $45M buyback and debt-free balance sheet offer downside protection. Read the latest analysis on the stock here.
Why INGN Stock advanced +0.14% Today — RQD Quant Desk Flash
$7.26 +0.14% NASDAQ • Live Quote vs Prior Daily Close (Synced Snapshot)
EXT / AFTER-HRS: $7.25
Inogen Inc (INGN) carries a Roarable Rating of E (Strong Sell) with 29/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.
ROARABLE E • RED ALERT
Cap $192.7M
⚡ INSTANT AI QUANT PREVIEW • $0 FREE TIER
Click Any Pre-Computed AI Quant Specialist Briefing on INGN Below — or Connect Your Own ChatGPT / Claude
🤖 Mara Quenwick • AI Quant Lead (Click for Instant Brief)
Is INGN stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
▼
As of 2026-11-01, Inogen Inc (NASDAQ: INGN) is rated E (Strong Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 29/100 at a spot price of $7.26 (+0.14% 1D, market cap $192.7M). Pillar breakdown: Fundamental Cash Engine 3/20, Institutional 13F & Options Flow 8/20, Executive Insider Alignment 7/20, FRED Macro Regime Fit 6/20, and SEC Balance-Sheet Forensics 7/20. Across 1016 tracked Health Care issuers, INGN ranks #956 in composite RQD confidence.
✓ Pre-computed one-to-many AI Quant brief
🤖 Ellis Vennor • AI Peer & Flow Quant (Click for Instant Brief)
How does INGN compare to ZJYL and SMTI in the Health Care sector?
▼
Within the Health Care sector (Industrial Specialties), INGN carries a Roarable E (29/100 RQD), trailing P/E of 8.5x, gross margin of 52.2%, and ROIC of -27.0%. By comparison, ZJYL (JIN MEDICAL INTERNATIONAL LTD. (Class A)) holds a D grade (47/100 RQD, P/E N/A, ROIC —, cap $294.2M) and SMTI (Sanara MedTech Inc.) posts a D+ grade (57/100 RQD, P/E 8.1x, ROIC 16.3%, cap $302.4M). Among the 5-stock peer group, SMTI leads on earnings multiple (8.1x) while SMTI leads on capital efficiency (16.3% ROIC).
✓ Pre-computed one-to-many AI Quant brief
🤖 Gideon Ashmere • AI SEC 10-K Forensics (Click for Instant Brief)
What are the biggest fundamental strengths and SEC risk factors for INGN?
▼
Per INGN's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001294133), Inogen Inc generated $295.3M in revenue (+5.9% YoY), $22.7M in net income, and -$13.7M in free cash flow against $298.6M in total assets and $0 in total debt. Key quantitative strengths: Established market leader in Health Care with deep daily trading liquidity.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.
✓ Pre-computed one-to-many AI Quant brief
🤖 AI Quant Disclosure: Roarable Analysts are proprietary AI Quant Specialists — not human financial advisors. Pre-computed one-to-many briefings above are free; interactive 1-on-1 Q&A, custom AI sifting/indicator alerts, and personal ChatGPT/Claude MCP connections require a $9.95/mo Pro account (currently waitlist-only).
INTERACTIVE SCENARIO DECK:
EXT / AFTER-HRS: $7.25 (-0.16%)🧬 Dilution Drag (+1.36% YoY Shares)⚙️ Cash Engine: 3/20 (E) • 0% FCF Margin
Verify 90D Bucket Audit →📊 Historical Track Record Warning: Scores below 50 (29/100 · E) historically underperformed SPY in 71% of rolling 90-day windows (-9.8% avg 90D alpha vs SPY • 29.0% hit rate).
Audit Bucket Track Record →RQD QUANT TACHOMETERRED ALERT • E
3-of-3 JEV AI Jury Bearish Warning
Cash
SEC
Whale
Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer
5-PILLAR SNOWFLAKE RADARRw E · Rk E
Each axis scored 0–20
12M PRICE TARGET CONE-13.1% Base Target
WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for INGN)Realized 20D OHLCV Swing Band: ±8.4%
Deterministic 5-Pillar Attribution (29/100 Composite)
🔍 WHY INGN SCORES 29/100 (E) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag
▲ #1 Bullish Driver: Whale & Options Positioning+8/20 pts (28% of score)
20D Institutional Volume Accumulation (±8.4% realized swing band)
▲ #2 Bullish Driver: SEC 10-K Forensic Risk+7/20 pts (24% of score)
Altman Z-Score 1.46 (DISTRESS RISK (<1.8)) • Piotroski F-Score 4/9
▼ #1 Drag / Risk Factor: Cash Engine Quality4/20 pts (-16 pt drag)
Capital intensity & 0% operating margin leave 16 pts on the table
📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current
Q1 (-3Q)Grade E$6.18+1.1% Next Q
21
Q2 (-2Q)Grade E$6.25+13.6% Next Q
24
Q3 (-1Q)Grade E$7.10+2.3% Next Q
26
CurrentGrade E$7.26-9.8% Hist 90D α
29
Trajectory: E (21) → E (29)Full Audit →
⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)CONTRARIAN TURNAROUND & SHORT-SQUEEZE DOSSIER
⚔️ Adversarial Opposing Case: What Could Spark a INGN Turnaround Squeeze
While INGN currently carries a cautious 29/100 (E) rating due to Cash Engine Quality (4/20), shorts face asymmetric squeeze risk if free cash flow inflects or management executes accretive buybacks.
🚀 Contrarian Squeeze Trigger #1
Established market leader in Health Care with deep daily trading liquidity.
🚀 Contrarian Squeeze Trigger #2
Options & Short-Covering Gamma: Reclaiming the 50-day SMA ($5.84) and Max Pain ($7.62) forces dealer call-delta covering toward $8.70.
🚀 Contrarian Squeeze Trigger #3
Forensic Repair Trigger: Halting share dilution (Dilution Drag (+1.36% YoY Shares)) or retiring high-cost debt immediately upgrades the SEC 10-K Forensic pillar.
🎲 LIVE PREDICTION MARKET ODDS TIED TO $INGN• $2.4M Crowd Pool • Kalshi / Polymarket Composite
Contract: “INGN Beats Next Quarter EPS Consensus (Dec 30, 2026) & Holds Above 200D SMA”
AUTOMATED RQD QUANT DESK MOVER BRIEFINGFull Market News Desk →
Why INGN Stock advanced +0.14% Today — RQD Quant Desk Flash
Inogen Inc (INGN) advanced +0.14% to $7.26, trading at 68% of its 52-week range ($5.05 – $8.29). Stretched risk/reward at 9x P/E (-27% return on capital) under elevated 10-year interest-rate pressure.
- ▸Technical Tape: Trading at 68% of its 52-week range ($5.05 – $8.29) with RSI-14 at 61.6 (BULLISH MOMENTUM).
- ▸Volatility Profile: Historical 20-day realized swing band of ±8.4% around $7.26 (no active unusual options sweep snapshot on file).
- ▸Fundamental Anchor: Roarable E (Strong Sell) backed by 52.2% gross margin and $0 annual free cash flow.
Live INGN Headlines & Catalysts
ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk
Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring INGN)
- ✓Walkthrough of INGN's RQD Radar, SEC cash-conversion gap & downside invalidation levels
- ✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
- ✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks
RQD INSIDER CLUB WAITLIST$49/YR PLANNED
Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?
INGN // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: +2.11%⚡ TESTING RESISTANCE
2026-10-30O $7.30H $7.30L $6.69C $7.26VOL 201.2K
RES: $7.41SUP: $4.43SMA50: $5.84SMA200: $6.22
PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK
INGN Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure
Share Count & Dilution Monitor (#25)
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
Reverse-DCF Expectations Hurdle (#30)
-4.3%/yr Implied 5Y Growth
vs. +5.9% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
Ellis Vennor Setup Ledger (#33)
No active Ellis Vennor swing setup published on INGN today. View full Setup Ledger →
🦋 Documented & Second-Order Butterfly Connections
Open Graph →
No direct multi-tier Butterfly edges indexed yet for INGN. Explore sector supply chains on /butterfly.
AI Analyst Theses, Washington Policy & Company Video
🎬 No recent verified company-specific video clip queued for INGN today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →
DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK
📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (INGN)
Health Care Rank #956 of 1016
⚔️ ZJYL vs INGN Full Matrix →
1. Head-to-Head Health Care Peer Comparison (INGN vs. ZJYL, SMTI, AGPU, LAKE)
Industry: Industrial Specialties (55 Tracked Issuers)Across 1016 tracked Health Care securities in the Roarable RQD universe, Inogen Inc (INGN) ranks #956 by composite RQD confidence (29/100, grade E) and #582 by equity capitalization ($192.7M). Within this direct 5-issuer industry benchmark cohort, SMTI leads on earnings valuation at 8.1x trailing P/E, while SMTI leads on capital efficiency and profitability with 16.3% ROIC and 92.7% gross margin. SMTI currently holds the highest overall quantitative score in the immediate peer group at 57/100 (D+) compared with INGN at 29/100 (E).
| Ticker / Company | Roarable Grade | RQD Score | Trailing P/E | Gross Margin | ROIC | 1D Change | Market Cap | Head-to-Head |
|---|---|---|---|---|---|---|---|---|
| INGN
ACTIVE
Inogen Inc | E | 29/100 | 8.5x | 52.2% | -27.0% | +0.14% | $192.7M | Benchmark Subject |
| ZJYL JIN MEDICAL INTERNATIONAL LTD. (Class A) | D | 47/100 | — | 29.2% | — | -2.10% | $294.2M | /zjyl-vs-ingn → |
| SMTI Sanara MedTech Inc. | D+ | 57/100 | 8.1x | 92.7% | 16.3% | +0.11% | $302.4M | /smti-vs-ingn → |
| AGPU Axe Compute Inc. | D- | 37/100 | — | — | -35.0% | -2.01% | $101.7M | /agpu-vs-ingn → |
| LAKE Lakeland Industries Inc. | D- | 38/100 | — | 32.9% | -9.5% | -1.11% | $88.2M | /lake-vs-ingn → |
2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)
SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0001294133In its most recent audited fiscal period (FY2025, filed 2025-12-31), Inogen Inc (INGN) reported GAAP revenue of $295.3M (+5.9% vs. FY2024 revenue of $278.8M , and +17.4% cumulative change since FY2023) , GAAP net income of $22.7M, operating cash flow of -$11.2M, and free cash flow of -$13.7M (-637.9% YoY). On the balance sheet, INGN closed FY2025 with $298.6M in total assets against $0 in total debt (Altman Z-Score: 1.46, Piotroski F-Score: 4/9).
| Fiscal Period | Filing Date | Revenue | Net Income | Operating Cash Flow | Free Cash Flow | Total Assets | Total Debt |
|---|---|---|---|---|---|---|---|
| FY2025 (FY) | 2025-12-31 | $295.3M | $22.7M | -$11.2M | -$13.7M | $298.6M | — |
| FY2024 (FY) | 2024-12-31 | $278.8M | $35.9M | $5.9M | $2.6M | $296.2M | — |
| FY2023 (FY) | 2023-12-31 | $251.6M | $102.4M | -$3.2M | -$3.2M | — | — |
3. INGN Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)
✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLEDIs INGN stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
As of 2026-11-01, Inogen Inc (NASDAQ: INGN) is rated E (Strong Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 29/100 at a spot price of $7.26 (+0.14% 1D, market cap $192.7M). Pillar breakdown: Fundamental Cash Engine 3/20, Institutional 13F & Options Flow 8/20, Executive Insider Alignment 7/20, FRED Macro Regime Fit 6/20, and SEC Balance-Sheet Forensics 7/20. Across 1016 tracked Health Care issuers, INGN ranks #956 in composite RQD confidence.
How does INGN compare to ZJYL and SMTI in the Health Care sector?
Within the Health Care sector (Industrial Specialties), INGN carries a Roarable E (29/100 RQD), trailing P/E of 8.5x, gross margin of 52.2%, and ROIC of -27.0%. By comparison, ZJYL (JIN MEDICAL INTERNATIONAL LTD. (Class A)) holds a D grade (47/100 RQD, P/E N/A, ROIC —, cap $294.2M) and SMTI (Sanara MedTech Inc.) posts a D+ grade (57/100 RQD, P/E 8.1x, ROIC 16.3%, cap $302.4M). Among the 5-stock peer group, SMTI leads on earnings multiple (8.1x) while SMTI leads on capital efficiency (16.3% ROIC).
What are the biggest fundamental strengths and SEC risk factors for INGN?
Per INGN's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001294133), Inogen Inc generated $295.3M in revenue (+5.9% YoY), $22.7M in net income, and -$13.7M in free cash flow against $298.6M in total assets and $0 in total debt. Key quantitative strengths: Established market leader in Health Care with deep daily trading liquidity.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.
Where is INGN trading relative to its 50-day, 200-day, and 52-week technical levels?
INGN last traded at $7.26 (+0.14% on volume of 257,606 shares), positioning the stock +24.32% above its 50-day simple moving average ($5.84) and +16.72% above its 200-day simple moving average ($6.22). Across its 52-week range of $5.05 to $8.29, INGN sits at the 68.2% percentile with a 14-day RSI of 61.6 (BULLISH MOMENTUM) and an implied next-earnings move of ±8.4% ($6.65 to $7.87).
INGN Investor FAQ & Complete 8-Part Research Index
100% OPEN ACCESS • SEC EDGAR × CBOE × FREDWhy is INGN stock moving today?
Why INGN Stock advanced +0.14% Today — RQD Quant Desk Flash. Stretched risk/reward at 9x P/E (-27% return on capital) under elevated 10-year interest-rate pressure.